FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

30175011000001102: Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Sep 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
94016501000001111 Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
94016601000001110 Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) Is a Empagliflozin 12.5mg / Metformin 850mg tablets true Inferred relationship Existential restriction modifier
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) Has specific active ingredient Empagliflozin true Inferred relationship Existential restriction modifier
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) Is a Synjardy true Inferred relationship Existential restriction modifier
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) Has active ingredient Metformin true Inferred relationship Existential restriction modifier
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Has AMP True Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start